Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sanara Capital is a health-tech venture capital fund established in 2023 and based in Israel. The firm specializes in financing rounds A and B for startups related to health technology, both domestically and internationally. As a follow-on fund to Sanara Ventures, which was founded in 2015, Sanara Capital benefits from a strong foundation supported by industry leaders such as Philips and Teva. This backing provides a significant advantage in the competitive health-tech landscape.
The firm currently manages a fund size of $100 million and has built a diversified portfolio of nearly 20 companies across both Sanara Capital and its predecessor, Sanara Ventures. The team comprises experienced professionals who leverage their extensive networks and expertise to support portfolio companies. Sanara Capital's office is located in Israel, and it aims to drive innovation in the healthcare sector through strategic investments.
Notable milestones include the establishment of a 100-person global advisory board that enhances operational support for startups, helping them navigate the complexities of the health-tech industry. This advisory board includes experts from various sectors, including hospitals, universities, and medical organizations across multiple countries.
Sanara Capital focuses on investments in the health-tech sector, specifically targeting Digital Health, Bio-Convergence, and Medical Devices. The firm primarily engages in Series A and B financing rounds for startups related to Israel, both within the country and abroad. This targeted approach allows Sanara Capital to identify and support innovative companies that are poised to make significant impacts in the healthcare industry.
The fund's investment strategy emphasizes operational support alongside capital investment. Sanara Capital seeks to partner with founders who demonstrate a strong vision and commitment to improving healthcare outcomes. The firm values companies that leverage technology to address pressing health challenges and improve patient care. Additionally, Sanara Capital's deal structure often includes co-investment opportunities, allowing for collaborative funding approaches that enhance the potential for success.
Sanara Capital has a diversified portfolio of nearly 20 companies across both its funds. Notable portfolio companies include:
This portfolio reflects Sanara Capital's commitment to supporting innovative health-tech solutions that address critical healthcare needs.
Assaf Barnea: CEO of both Sanara Ventures and Sanara Capital. He has a diverse background, including experience in law, business administration, political science, and psychology. Barnea is also the chairman of the Israel Exports Institute's Life Science Advisory Board and an advisor to the World Bank's IFC venture capital team.
Hila Zur: [Role not specified].
Haisong Tang: [Role not specified].
Jan Kimpen: [Role not specified].
Efi Hershkovitz: [Role not specified].
Eli Yered: [Role not specified].
Assaf Barnea: [Role not specified].
Eran Toledo: [Role not specified].
Andrei Soran: [Role not specified].
Daniel Kahn: [Role not specified].
Tal Menipaz: [Role not specified].
Dr. Janette Lazarowitz: [Role not specified].
Dr. Jonathan Seah: [Role not specified].
Prof. Pinny Halpern: [Role not specified].
David Ben Ami: [Role not specified].
Yoav Shaked: [Role not specified].
To pitch to Sanara Capital, founders should visit their website at sanaracapital.com. The pitch deck should include a comprehensive overview of the business model, market analysis, financial projections, and the team’s background. Sanara Capital prefers detailed presentations that clearly outline the startup's unique value proposition and competitive advantages.
Response times may vary, but founders can expect to hear back within a few weeks after submission. Warm introductions are encouraged, as they can enhance the likelihood of a favorable review.
In September 2024, Sanara Capital co-led a Series A investment in Discure Technologies, which raised a total of $16 million. This funding round included $11 million in Series A financing and $5 million in SAFE prior funding. Discure Technologies develops bioelectronic implantable devices aimed at treating degenerative disc disease.
On January 25, 2026, Sanara Capital published a blog post discussing strategic outlooks and milestones for one of their portfolio companies, Ukko. This reflects the firm's ongoing engagement with its portfolio and commitment to supporting their growth.
What are Sanara Capital's investment criteria?
Sanara Capital primarily invests in health-tech startups focusing on Digital Health, Bio-Convergence, and Medical Devices. The firm targets Series A and B financing rounds for Israeli-related startups, both domestically and internationally.
How can founders apply or pitch to Sanara Capital?
Founders can pitch their startups through the Sanara Capital website at sanaracapital.com. It is recommended to include a detailed business plan and financial projections in the pitch deck.
What makes Sanara Capital different from other venture capital firms?
Sanara Capital offers more than just capital; it provides access to a vast network of clinical and commercial resources through partnerships with industry leaders like Philips and Teva. The firm also has a 100-person global advisory board that enhances operational support for portfolio companies.
What is the geographic scope of Sanara Capital's investments?
Sanara Capital primarily focuses on Israeli-related startups, but it also considers opportunities in international markets, particularly those that align with its health-tech investment strategy.
What is the typical check size for investments?
Sanara Capital typically invests several million dollars in follow-on rounds, with initial checks during the incubator era reaching up to $1 million.
What kind of post-investment involvement can portfolio companies expect?
Sanara Capital is actively involved with its portfolio companies, providing operational support, strategic guidance, and access to its extensive network to help startups navigate the complexities of the health-tech landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.